In a mouse model of Sjögren’s syndrome, HMGB1 inhibition restored saliva and tear secretion [78,79], suggesting HMGB1 inhibition may represent a new therapeutic strategy for treating the disease. The gene discussed is HMGB1; the disease is Sjogren syndrome.